Summary
Oxidized low-density lipoprotein (ox-LDL) has been shown to alter the migratory and proliferative activities of the vascular endothelial cells (EC) in response to serum and growth factors. The mechanism underlying the antiproliferative effect of ox-LDL on vascular EC has not been fully elucidated. In this report, we show that exposure of vascular EC to ox-LDL results in a marked reduction of the membrane-associated Ras protein. Further study shows that in ox-LDL-treated EC, reduction of the membrane-associated Ras protein is correlated with a reduced amount of active Ras (Ras-guanosine triphosphate), indicating that the Ras signaling pathway is attenuated. The attenuation of the Ras signaling pathway in ox-LDL-treated EC may thus be responsible for the retarded response to the mitogenic stimulation of serum and growth factors.
Similar content being viewed by others
References
Armstrong, D. A. Oxidized LDL ceroid, and prostaglandin metabolism in human atherosclerosis. Med. Hypotheses 38:244–248; 1992.
Björkerud, B.; Björkerud, S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscles, macrophages, and fibroblasts. Arterioscler. Thromb. Vasc. Biol. 16:416–424; 1996.
Boulanger, C. M.; Tanner, F. C.; Bea, M. L.; Hahn, A. W.; Werner, A.; Luscher, T. F. Oxidized low density lipoproteins induce mRNA expression and release of endothelium from human and porcine endothelium. Circ. Res. 70:1191–1197; 1992.
Carlos, T. M.; Harlan, J. M. Membrane proteins involved in phagocyte adherence to endothelium. Immunol. Rev. 114:5–28; 1990.
Chatterjee, S. Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation. Mol. Cell. Biochem. 111:143–147; 1992.
Chatterjee, S.; Bhunia, A.; Snowden, A.; Han, H. Oxidized low density lipoproteins stimulate galatosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells. Glycobiology 7:703–710; 1997.
Chen, J. K.; Hoshi, H.; McClure, D. B.; Mckeehan, W. L. Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein-deficient serum. J. Cell. Physiol. 129:207–214; 1986.
Chen, C. H.; Jiang, W.; Via, D. P.; Luo, S.; Li, T. R.; Lee, Y. T.; Henry, P. D. Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation 101:171–177; 2000.
Chin, J. H.; Azhar, S.; Hoffman, B. B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J. Clin. Invest. 89:10–18; 1992.
Chomczynski, P.; Sacchi, N. Single step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156–159; 1987.
Chow, S. E.; Lee, R. S.; Sih, S. H.; Chen, J. K. Oxidized LDL promotes vascular endothelial cell pinocytosis via a prooxidation mechanism. FASEB J. 12:823–830; 1998.
Cissel, D. S.; Beaven, M. A. Disruption of Raf-1/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells. J. Biol. Chem. 275:7066–7070; 2000.
Cushing, S. D.; Berliner, J. A.; Valente, A. J., et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA 87:5134–5138; 1990.
Cuthbert, J. A.; Lipsky, P. E. Suppression of the proliferation of ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism. Cancer Res. 55:1732–1740; 1995.
Hamsten, A.; de Faire, U.; Walldius, G.; Dahlen, G.; Szamosi, A.; Landau, C.; Blomback, M.; Wiman, B. Plasminogen activator inhibitor in plasma: risk factor recurrent myocardial infraction. Lancet 2:3–9; 1987.
Havel, R. J.; Eder, H. A.; Bradgon, J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1345–1353; 1955.
Heermeier, K.; Leicht, W.; Palmetshofer, A.; Ullirich, M.; Wanner, C.; Galle, J. Oxidized LDL suppresses NF-kappa B and overcomes protection from apoptosis in activated endothelial cells. J. Am. Soc. Nephrol. 12:456–463; 2001.
Henriksen, T.; Evensen, S. A.; Caelander, B. Injury to human endothelial cells in culture induced by low density lipoproteins. Scan. J. Clin. Lab Invest. 39:361–368; 1979.
Hessler, J. R.; Morel, D. W.; Lewis, L. J.; Chisolm, G. M. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 3:215–222; 1983.
Hessler, J. R.; Robertson, A. L., Jr.; Chinsolm, G. M. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32:213–229; 1979.
Huang, J.; Mohammadi, M.; Rodrigues, G. A.; Schlessinger, J. Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis. J. Biol. Chem. 270:5065–5072; 1995.
Kato, K.; Cox, A. D.; Hisaka, M. M.; Graham, S. M.; Buss, J. E.; Der, C. J. Isoprenoid addition to Ras protein is the critical modification for its membrane association and transformating activity. Proc. Natl. Acad. Sci. USA 89:6403–6407; 1992.
Khan, B. V.; Parthasarathy, S. S.; Alexander, R. W.; Medford, R. M. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95:1262–1270; 1995.
Kikuchi, A.; Williams, L. T. The post-translation modification of ras p21 is important for Raf-1 activation. J. Biol. Chem. 269:20054–20059; 1994.
Liao, J. K.; Clark, S. L. Regulation of G-protein αi2 subunit expression by oxidized low-density lipoprotein. J. Clin. Invest. 95:1457–1463; 1995.
Lin, S. J.; Jan, K. M.; Weinbaum, S.; Chien, S. Transendothelial transport of low density lipoprotein in association with cell mitosis in rat aorta. Arteriosclerosis 9:230–236; 1989.
Linder, V.; Lappi, D. A.; Baird, A.; Majack, R. A.; Reidy, M. A. Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res. 68:106–113; 1991.
Lowry, O. H.; Rosenbrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–270; 1951.
Morel, D. W.; Hessler, J. R.; Chisolm, G. W. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J. Lipid Res. 24:1070–1076; 1983.
Murugesan, G.; Chisolm, G. M.; Fox, P. L. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J. Cell Biol. 120:1011–1019; 1993.
Napoli, C.; Quehenberger, O.; de Nigris, F.; Abete, P.; Glass, C. K.; Palinski, W. Midly oxidized LDL activates multiple apoptosic signaling pathways in human coronary cells. FASEB J. 14:1996–2007; 2000.
Nishida, Y.; Oda, H.; Yorioka, N. Effect of lipoproteins on mesangial cell proliferation. Kidney Int. Suppl. 71:S51-S53; 1999.
Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:351–358; 1979.
Pomerantz, K. B.; Lander, H. M.; Summers, B.; Robishaw, J. D.; Balcueva, E.; Hajjar, D. P. G-protein-mediated signalling in cholesterol-enriched arterial smooth muscle cells. 1. Reduced membrane-associated G-protein content due to diminished isoprenylation of G-γ subunits and p21 ras. Biochemistry 36:9523–9531; 1997.
Rajavashisth, T. B.; Andalibi, A.; Territo, M. C.; Berliner, J. A.; Nava, M.; Fogelman, A. M.; Lusis, A. J. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344:254–257; 1990.
Rangaswamy, S.; Penn, M. S.; Saidel, G. M.; Chisolm, G. M. Exogenous oxidized low density lipoprotein injures and alters the barrier function of endothelium in rats in vivo. Circ. Res. 80:37–44; 1997.
Reid, V. C.; Mitchinson, M. J.; Skepper, J. N. Cytoxicity of oxidized low-density lipoprotein to mouse peritoneal macrophages: an ultrastructural study. J. Pathol. 171:321–328; 1993.
Rosenfeld, M. E.; Ross, R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 10:680–687; 1990.
Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801–809; 1990.
Sambrook, J.; Fritsch, E. F.; Maniatis, T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
Schuh, J.; Novogrodsky, A.; Haschemeyer, R. H. Inhibition of lymophocyte mitogenesis by autoxidized low-density lipoprotein. Biochem. Biophys. Res. Commun. 84:763–768; 1978.
Steinberg, D. Oxidative modification of LDL and atherogenesis. Circulation 95:1062–1071; 1997.
Sugawa, M.; Ikeda, S.; Kushima, Y.; Takashima, Y.; Cynshi, O. Oxidized low density lipoprotein caused CNS neuron cell death. Brain Res. 761:165–172; 1997.
Wang, D. W.; Yang, V.; Chen, J. K. Oxidized LDL inhibits vascular endothelial cell morphogenesis in culture In Vitro Cell. Dev. Biol. 33:248–255; 1997.
Wheeler, D. C.; Chana, R. S.; Topley, N.; Petersen, M. M.; Davies, M.; Williams, J. D. Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int. 45:1628–1636; 1994.
Yang, C. M.; Chien, C. S.; Hsiaooo, L. D.; Pan, S. L.; Wang, C. C.; Chiu, C. T.; Lin, C. C. Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway. Br. J. Pharm. 132:1531–1541; 2001.
Yui, S.; Sasaki, T.; Miyazaki, A.; Horiuchi, S.; Yamazaki, M. Induction of murine macrophage growth by modified LDLs. Arterioscler. Thromb. 13:331–337; 1993.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chow, SE., Chu, WK., Shih, S.H. et al. Exposure to oxidized low-density lipoprotein reduces activable ras protein in vascular endothelial cells. In Vitro Cell.Dev.Biol.-Animal 38, 320–325 (2002). https://doi.org/10.1290/1071-2690(2002)038<0320:ETOLDL>2.0.CO;2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1290/1071-2690(2002)038<0320:ETOLDL>2.0.CO;2